Trifluridine/Tipiracil Hcl
Brand name: Lonsurf
Rank #361 of 500 drugs by total cost
$27.3M
Total Cost
2,430
Total Claims
$27.3M
Total Cost
145
Prescribers
$11K
Cost per Claim
0
Beneficiaries
2,432
30-Day Fills
$188K
Avg Cost/Provider
17
Avg Claims/Provider
About Trifluridine/Tipiracil Hcl
Trifluridine/Tipiracil Hcl (sold as Lonsurf) was prescribed 2,430 times by 145 Medicare Part D providers in 2023, costing the program $27.3M. At $11K per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 358 | Colchicine (Colchicine) | $27.5M | 314,046 |
| 359 | Valsartan/Hydrochlorothiazide (Valsartan-Hydrochlorothiazide) | $27.5M | 510,583 |
| 360 | Ropinirole Hcl (Ropinirole Hcl) | $27.5M | 1,204,903 |
| 361 | Trifluridine/Tipiracil Hcl (Lonsurf) | $27.3M | 2,430 |
| 362 | Memantine Hcl/Donepezil Hcl (Namzaric) | $27.2M | 46,134 |
| 363 | Solifenacin Succinate (Solifenacin Succinate) | $27.1M | 343,174 |
| 364 | Insulin Aspart (Niacinamide) (Fiasp Flextouch) | $27.0M | 24,598 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology